19 completed, 8 terminated, 4 withdrawn, 2 not yet recruiting. 37 Phase 2, 6 Phase 3, 4 Phase 1.
Follow Glutamine: new trials by email Literature Review of Glutamine trials Research Report on Glutamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of First-line Gemcitabine and Nab-paclitaxel With or Without L-glutamine in Advanced Pancreatic Cancer Gemcitabine (1000 mg/m2), Nab-paclitaxel, L-glutamine - Pancreatic Cancer | Phase 2 | Not yet recruiting | Jun Gong, MD | 200 | 2026-12-01 | 2026-10-08 |
| A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic Radiotherapy five - flavor sophora flavescens enteric - coated capsules plus glutamine and warm - water sitz baths, glutamine and warm - water sitz baths - Radiation - Induced Proctitis | Phase 2 | Not yet recruiting | Peking University First Hospital | 124 | 2025-06-30 | 2025-07-08 |
| Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury. Thalidomide, Glutamine, Thalidomide+Glutamine - Radiation Enteritis | Phase 2 | Recruiting | Yongquan Shi | 150 | 2024-09-30 | 2026-03-27 |
| Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia L-glutamine - Pulmonary Artery Pressure, Thalassemia | Phase 2 / Phase 3 | Completed | Mazandaran University of Medical Sciences | 8 | 2023-08-15 | 2025-10-07 |
| A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia Glutamine, Placebo - Functional Dyspepsia | Phase 1 / Phase 2 | Completed | David J. Cangemi | 12 | 2023-02-16 | 2026-02-03 |
| Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) Alanyl-glutamine - Clostridioides Difficile Infection, Clostridium Difficile Infection | Phase 2 | Recruiting | University of Virginia | 260 | 2021-06-01 | 2024-10-26 |
| Treatment of Adults With Generalized Anxiety Disorder Using Glutamine L Glutamine, Placebos - Generalized Anxiety Disorder | Phase 2 | Terminated | Hospital Universitario Dr. Jose E. Gonzalez | 38 | 2019-01-18 | 2021-02-11 |
| A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers Beta-Glucan, Glutamine, Immunoglobuin - Metastatic Cancer, Chemotherapy | Phase 2 / Phase 3 | Unknown | E-DA Hospital | 90 | 2018-01-04 | 2021-01-25 |
| Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma Palifermin, Panobinostat, Gemcitabine - Lymphoma | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2017-06-01 | 2017-04-21 | |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype Lenalidomide, Vorinostat, Gemcitabine - Lymphoma | Phase 1 / Phase 2 | Terminated | M.D. Anderson Cancer Center | 8 | 2016-06-22 | 2019-12-13 |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma Busulfan, Caphosol, Glutamine - Lymphoma | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2016-06-01 | 2016-05-04 | |
| Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma Carfilzomib, SAHA, Gemcitabine - Myeloma | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2014-09-01 | 2014-07-11 | |
| Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy Glutamine, Placebo - Breast Cancer | Phase 2 | Terminated | University of Arkansas | 14 | 2014-06-01 | 2019-05-29 |
| Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation Standard of care ADT + (HMB + arginine + glutamine), Standard of care ADT - Prostate Cancer | Phase 2 | Completed | Medical College of Wisconsin | 48 | 2014-03-01 | 2023-09-22 |
| Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma Azacitidine, Vorinostat, Gemcitabine - Advanced Cancers, Lymphoma | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 61 | 2013-11-07 | 2020-01-27 |
| Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib glutamine, quality-of-life assessment, placebo - Chemotherapeutic Agent Toxicity, Multiple Myeloma | Phase 2 | Terminated | Beth Faiman | 9 | 2013-02-01 | 2019-10-22 |
| Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery Glutamine, Ringer's solution - Rheumatic Heart Disease, Coronary Heart Disease | Phase 2 | Completed | Yuejiang Liu | 33 | 2013-01-01 | 2014-05-28 |
| Safety of Gastric Volume Emptying After the Intake of Maltodextrin and Glutamine Maltodextrin, Glutamine - Pulmonary Aspiration of Gastric Contents, Adverse Effects in the Therapeutic Use of Other and Unspecified General Anaesthetics | Phase 2 | Completed | Federal University of Mato Grosso | 11 | 2012-03-01 | 2013-02-25 |
| Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure Glutamine and Fish Oil Supplementation, Placebo - Heart Failure | Phase 2 / Phase 3 | Completed | Columbia University | 31 | 2011-11-01 | 2020-12-22 |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin Glutamine - Colorectal Carcinoma, Neoplasms, Colorectal | Phase 2 | Withdrawn | AHS Cancer Control Alberta | 2011-10-01 | 2016-02-24 |
Showing 20 of 37. Sign in to see all of them.
Lymphoma (5) · Anemia, Sickle Cell (4) · Thalassemia (4) · Lymphoma, Large B-Cell, Diffuse (3) · Colorectal Neoplasms (2) · Multiple Myeloma (2) · Muscular Dystrophy, Duchenne (2) · Neoplasm Metastasis (2) · Peripheral Nervous System Diseases (2) · Sepsis (2) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Clostridium Infections (1) · Coronary Disease (1) · Critical Illness (1)
M.D. Anderson Cancer Center (5) · AHS Cancer Control Alberta (2) · Columbia University (2) · Ain Shams University (1) · Assistance Publique - Hôpitaux de Paris (1) · Beth Faiman (1) · Christiana Care Health Services (1) · Cooperative International Neuromuscular Research Group (1) · David J. Cangemi (1) · E-DA Hospital (1) · Emmaus Medical, Inc. (1) · Emory University (1) · Federal University of Mato Grosso (1) · Hospital Universitari Son Dureta (1) · Hospital Universitario Dr. Jose E. Gonzalez (1)
United States (21) · China (2) · Brazil (1) · Canada (1) · Egypt (1) · France (1) · Iran (1) · Mexico (1) · Spain (1) · Taiwan (1)
Yago Nieto, MD, PHD (4) · Michael Sawyer, MD (2) · Yutaka Niihara, MD (2) · Augusta Saulys, MD (1) · Barbara Jean Bambach, MD (1) · Beth Faiman (1) · Claudia Morris, MD (1) · David Cangemi, MD (1) · Diana M Escolar, MD (1) · GHada A. Saleh, MRCPCH (1) · Gunnar Buyse, MD, PhD (1) · Julia L. Glade-Bender, MD (1) · Jun Gong, MD (1) · Kathryn Bylow, MD (1)
PMID 15984021, PMID 16086046, PMID 17636753, PMID 19421321, PMID 22261571, PMID 25861285, PMID 26269566, PMID 29392418, PMID 30108163, PMID 37474181, PMID 38775255
P50AT000076 (1)